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Surface pHPolysialic acid (polySia) and oligosialic acid (oligoSia) chains are linear polysaccharides composed of sialic
acid monomers. The majority of biological poly/oligoSia chains are bound to membranes. There is a large di-
versity of membrane poly/oligoSia in terms of chain length, occurrence, biological function, and the mode of
membrane attachment. Poly/oligoSia can be anchored to a membrane via a phospholipid (polySia in bacte-
ria), a glycosphingolipid (oligoSia in gangliosides), an integral membrane glycoprotein, or a glycoprotein at-
tached to a membrane via glycosylphosphatidylinositol. In eukaryotic cells, the attachment of a poly/oligoSia
chain to the membrane anchor is usually through α-2,3-glycosidic linkage to a galactose. In prokaryotic cells
this attachment is proposed to occur through glycosidic linkage to the phosphate group of a phospholipid.
Both long polySia chains attached to membrane proteins and short oligoSia attached to glycosphingolipids
or membrane proteins are frequently found in neural membranes. In humans, poly/oligoSia is involved in de-
velopment and plasticity of the brain, pathophysiology of schizophrenic brains, cancer metastasis, neuroinva-
sive potential of pathogenic bacterial strains, and the immune response. Biological roles of poly/oligoSia are
based on its ability to modulate repulsive and attractive interactions between twomolecules, and its ability to
modulate membrane surface charge density, pH at the membrane surface, and membrane potentials.r, Cellular and Developmental
SA. Tel.: +1 303 492 8377;
.
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Polysialic acid (polySia) and oligosialic acid (oligoSia) chains are
linear polysaccharides composed of sialic acid monomers: N-
acetylneuraminic acid (Neu5Ac), N-glycolylneuraminic acid (Neu5Gc)
or deaminated neuraminic acid (KDN; 3-deoxy-D-glycero-D-galacto-
nonulosonic acid) (Fig. 1), joined internally by α-2,8-, α-2,9-, or
α-2,8/α-2-9-ketosidic linkages [1–11]. In the case of oligoSia,
there are also α-2,4-ketosidic linkages (in gangliosides, [12]) and
α-2,5-ketosidic linkages (in glycoproteins, [13]). Poly/oligoSia
monomers have a common neuraminic acid (Neu) or KDN backbone
(Fig. 1). Although humans are genetically unable to produce Neu5Gc,
human embryonic stem cells express this immunogenic nonhuman Sia
[14] and an accumulation of Neu5Gc in human cancer cells is observed
[15]. The expression level of KDN in humans is as low as b0.01 mol% of
Neu5Ac [15]. Neither poly/oligo-Neu5Gc nor poly/oligo-KDN chains
were detected in humans. Sia monomers within a poly/oligoSia chain
are negatively charged at physiological pH due to the presence of a car-
boxylic group with a pKa~2.6. Poly/oligoSia chains usually consists of
only one kind of monomers (thus forming a homopolymer), e.g.
(α-2,8-Neu5Ac)n or (α-2,8-Neu5Ac/α-2,9-Neu5Ac)n. The majorityof poly/oligoSia biopolymers discovered so far are connected to a
membrane.
There is a large diversity of membrane poly/oligoSia in terms of:
- chain length (DP, degree of polymerization) — starting from a few
monomers and extending to DP~400 [16,17];
- occurrence— for example, they can be found in neural cells in verte-
brates, human dendritic cells, human leukocytes, human milk fat
globules, neural stem cell-derived progenitors, human cancer cells,
bacterial cells, or in invertebrates— e.g. sea urchin sperm ﬂagellum;
- biological function — for example, they can inﬂuence fertilization,
induce neuronal plasticity of human nervous system, or enhance
the metastatic potential of tumor cells;
- mode of membrane attachment— they can be joined to a membrane
lipid (e.g. in the case of oligosialo-gangliosides) or a membrane
protein (e.g. in the case of polysialylated neural cell adhesion
molecule, NCAM) (see references in the next chapters).
The action of poly/oligoSia results from a combination of:
- repulsive interactions — between polySia chains or between poly-
Sia chains and membrane proteins;
- attractive interactions — between poly/oligoSia chains and mem-
brane proteins, membrane lipids, or soluble proteins/peptides/
proteoglycans;
- modulation of surface charge density — because of the negative
charge of the poly/oligoSia monomers;
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Fig. 1. The chemical structure of sialic acids: N-acetylneuraminic acid (Neu5Ac), N-
glycolylneuraminic acid (Neu5Gc), deaminated neuraminic acid (KDN). A— neuraminic
acid backbone, B — KDN backbone.
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groups present in poly/oligoSia chains;
- modulation of membrane potentials (transmembrane potential and
surface potential) — arising from poly/oligoSia transmembrane
translocation or from the changes of surface charge density and
surface pH (see references in the next chapters).
In bacteria, the proteins involved in polySia synthesis and translo-
cation are coded by a gene cluster designated the kps gene cluster
(Escherichia coli) or the cps gene cluster (Neisseria meningitidis) [18].
In eukaryotic cells, there are two polysialyltransferases in the Golgi
complex involved in biosynthesis of long polySia chains: ST8SiaII
(STX) and ST8SiaIV (PST). There are also several other sialyltrans-
ferases, located in the ER or Golgi membranes, involved in biosynthe-
sis of oligoSia chains (attached to lipids or to proteins): ST8SiaIII and
ST8SiaVI that catalyze di- and tri-sialylation of glycoproteins, and
ST8SiaI and ST8SiaV that catalyze di- and tri-sialylation of ganglio-
sides [19].
It was proposed [20] that di-, oligo- and polySia could be deﬁned
as polymerized forms containing DP 2, DP 3–7, and DP 8 or more
Sia residues, respectively. This classiﬁcation is based on the recogni-
tion of each class by anti-di/oligo/polySia antibodies. The antibodies
recognizing di/oligo/polySia glycotope are classiﬁed into three groups
[20]: group I antibodies recognize chains of DP 8 or greater and the
nonreducing terminal residues do not participate in the polySia rec-
ognition, group II antibodies recognize both oligoSia with DP 3–7
and longer polySia chains, and the nonreducing terminal residues
are involved in antigen recognition, group III antibodies recognize
chains of DP 2–4 but they do not bind to polySia, a subgroup within
group III recognizes only diSia structures.
2. Structure, occurrence, and function of membrane polySia
The majority of poly/oligoSia is membrane-bound, although there
are few examples of non-membrane polySia (or polySia for whichmembrane attachment has not been yet reported), e.g. polySia on a
soluble polysialoglycoprotein (PSGP) in rainbow trout eggs cortical
alveoli [21]. Fig. 2 shows the chemical structure of poly-α-2,8-
Neu5Ac. A non-reducing residue (left side of Fig. 2) is followed by a
linear homopolymer ending with a reducing end (right side of
Fig. 2). Neu5Ac monomers are joined internally by α-2,8-ketosidic
linkages. The reducing end is usually conjugated to a membrane an-
chor. PolySia chain growth occurs by the addition of Sia to the non-re-
ducing terminus of the growing chain (tail growth). There are several
types of cell type-speciﬁc poly/oligoSia membranemolecular anchors,
such as which can be a phospholipid molecule (in the case of polySia
in bacteria), a glycosphingolipid molecule (in the case of oligoSia in
gangliosides), or a membrane protein molecule (see Fig. 3).
2.1. PolySia on phospholipids in the outer membrane of some capsule-
expressing bacteria
PolySia chains attached to the outer bacterial membrane form a cap-
sule surrounding neuroinasive E. coli K1, N. meningitidis serogroups B
and C, and some other gram-negative bacterial strains, e.g. Pasteurella
haemolytica A2, andMoraxella nonliquefaciens [3,22–27]. PolySia chains
are proposed to be glycosidically linked to the phosphate moiety of
phospholipid molecules in the outer layer of the outer bacterial mem-
brane [28]. The polyanion capsule conceals surface structures that can
activate complement, thus rendering bacterial cells resistant to phago-
cytosis by neutrophils [25]. E. coli K1 capsule may be vital for intracellu-
lar survival and for crossing the blood–brain barrier (BBB) [29], the
capsule may also adversely affect bacterial ability to colonize as it can
sterically hinder the surface-expressed adhesins [30] therefore it may
be hypothesized that the K1 capsule may be lost within the BBB in
some cases. PolySia chains are poorly immunogenic because of structur-
al identity of bacterial polySia and human polySia on neural cells [22]. It
was suggested that polySia in the inner membrane of E. coli K1 can be
anchored to a 20 kDa membrane protein acceptor and also to undeca-
prenyl phosphate (P-C55) [31,32]. Thus polySia chains may be translo-
cated across the inner membrane while linked to P-C55 [32].
2.2. PolySia on NCAM in the plasma membrane of neural cells, neural stem
cell-derived progenitors/precursors cells, cancer cells, and leukocytes
The major membrane protein carrier of polySia in mammalian
cells is NCAM. There are several isoforms of NCAM, three of which
can carry polySia: NCAM-180 and NCAM-140 (integral membrane
isoforms), and NCAM-120 (isoform that is anchored to the plasma
membrane via a glycosylphosphoinositol (GPI)) [5,33–35]. No more
than 35% colocalization of polysialylated and non-polysialylated
NCAMwith the lipid raft marker (cholera toxin subunit B) is observed
[36]. The polySia-modiﬁcation of NCAM is correlated with brain de-
velopment. In the adult brain, the polysialylated NCAM is expressed
only in some regions that are associated with plasticity (e.g. hippo-
campus). PolySia on NCAM regulates neural cell migration and differ-
entiation during brain development, and is associated with
neurogenesis and synaptic plasticity in the adult brain. The loss of
polySia on NCAM converts NCAM from a molecule that induces plas-
ticity during neural development to one that mediates stability in
adult brain [37] due to polySia-mediated modulation of cell-cell inter-
actions. PolySia chains can be attached to both N- and O-linked oligo-
saccharides at the extracellular domain of NCAM [33,38–40].
Polysialylated NCAM is found on several neural stem cell-derived
progenitors/precursor cells, including oligodendrocytes, astrocyte
precursor cells, astroblasts, neuroblasts, and glial precursors [41–43].
PolySia on NCAM is also expressed in several tumor cells where it
can function as an oncodevelopmental antigen and contribute to can-
cer metastasis [1,44]. Polysialylated NCAM is also present on the sur-
face of immune system cells, such as human and murine leucocytes,
to modulate immune responses [17].
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Fig. 2. The chemical structure of poly-α-2,8-N-acetylneuraminic acid (poly-α-2,8-Neu5Ac). The right end of the chain is usually called the reducing end of the chain even if it is
conjugated through the hydroxyl group at C2. Biological polySia is usually conjugated to a membrane anchor through their reducing end.
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plasma membranes of brain progenitors
SynCAM 1 is an integral membrane protein that is polysialylated
in NG2+ progenitors in the early postnatal brain [45]. PolySia on Syn-
CAM is located on N-glycans of the ﬁrst Ig domain, two domains away
from the membrane surface. This spacing is the same as for polysialy-
lated NCAM, suggesting a constant positioning of active sites of STX/
PST polysialyltranserases relative to the membrane. Although both
SynCAM and NCAM belong to the superfamily of Ig proteins and
both are cell adhesion molecules, their functions are distinct. SynCAM
induces synaptic differentiation and organizes excitatory synapses
through interactions across the nascent and mature synaptic cleft.galactose
glucose
sialic acid 
core oligosaccharides
phosphate group 
C
D
N-acetylgalactosamine 
Fig. 3. Modes of attachment of poly/oligoSia chains toNG2+ progenitors can differentiate into oligodendrocytes and astro-
cytes, and can also give rise to neurons. Because these progenitors can
form synapse-like connections with neurons, polysialylated SynCAM
may also serve synapse-organizing function in NG2+ precursor cells
[46].
2.4. PolySia on sodium and potassium channels in plasma membranes
PolySia chains were found to be linked to the sodium channel in
the plasma membrane of Electrophorus electricus electroplax (special-
ized muscle cells) [47] and neurons in rat brains [48], and to the po-
tassium channel (through an N-glycan structure) in the plasma
membrane of neurons in adult rat brain [49]. The polySia chainspolySia on an N-glycosylated
integral protein 
polySia on an O-glycosylated 
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lylation of reconstituted rat brain sodium channel with neuramini-
dase signiﬁcantly decreased the conductivity of the channel [50]
and the removal of sialyl residues from Kv1.1 and 1.2 channels de-
creased their activation rates and increased positive potential re-
quired for their activation [51,52].
2.5. PolySia on CD36 glycoprotein in human fat globule outer membrane
The envelopes that enclose the lipid core of mature human milk
fat globules consist of an inner lipid monolayer derived from the cyto-
plasmic leaﬂet of the endoplasmic reticulum (ER) membrane, and an
outer lipid bilayer derived from the plasma membrane of epithelial
cells of mammalian glands [53]. Integral membrane protein CD36 is
located in the outer bilayer and contains polySia chains connected
to the protein through an O-linked glycan [54]. PolySia in human
milk may be important for neonatal development in terms of protec-
tion and nutrition because of the low Neu5Ac synthetic capacity and
the high Neu5Ac requirement for neonatal brain development and
cognition [55].
2.6. PolySia on Megalin glycoprotein in plasma membranes of normal
and carcinoma cells in rats
Megalin, an integral membrane protein expressed in various nor-
mal rat tissues, carcinoma rat tissues, and carcinoma cell lines, carries
polySia chains (poly-α-2,8-KDN) as a part of O-glycosidically linked
oligosaccharides [56]. Megalin functions as a receptor for a multitude
of ligands and may regulate calcium homeostasis. Negatively-charged
poly-α-2,8-KDN chains may be involved in calcium binding. It has
been shown that glycosylation of Megalin is essential for induction
of pathogenic autoimmune response in Heymann nephritis disease
[57].
2.7. PolySia on Flagellasialin glycoproteins and on gangliosides in the
rafts of plasma membrane of sea urchin sperm ﬂagella
Flagellasialin is anα-2,9-linked polySia-containing glycoprotein in
the plasmamembrane of sea urchin sperm ﬂagella [58,59]. Flagellasialin
contains a single transmembrane segment, is heavilyO-glycosylated, and
is localized in membrane rafts. The average DP of polySia (polyNeu5Ac)
chains on Flagellasialin is reported to be 15, and the non-reducing termi-
nus of the chain is capped by a sulfate group. Flagellasialin may regulate
intracellular calcium level, sperm motility, and fertilization [62]. The
presence of unique gangliosides containing α-2,8-linked di-, tri-, and
tetra-Neu5Ac structures has also been documented in rafts containing
Flagellasialin [60,61].
2.8. PolySia on Neuropilin-2 glycoprotein in the plasma membrane of
human dendritic cells
Neuropilin-2 (NRP-2) is a polysialylated plasma membrane recep-
tor expressed on the surface of human dendritic cells [62]. PolySia
chains are probably added to the O-linked glycans of NRP-2, and
their removal promotes dendritic cell-induced activation and prolif-
eration of T lymphocytes. Thus polySia chains on NRP-2 can modulate
dendritic cell–T lymphocyte interactions. It was also shown that poly-
Sia is required for Neuropilin-2a/b-mediated control of CCL21-driven
chemotaxis of mature dendritic cells, and for their migration in vivo
[63].
2.9. PolySia on polysialyltransferases PST and STX in Golgi membranes
The polysialyltransferases STX (ST8SiaII) and PST (ST8SiaIV) cata-
lyze formation of polySia chains on α-2,3- or α-2,6-sialylated N-
linked glycans of NCAM [64]. STX is the predominantpolysialyltransferase during embryonic development, whereas PST
plays a major role in the adult brain [35]. Although both PST and
STX are autopolysialylated in transfected cells [65,66], this modiﬁca-
tion does not appear to occur during neural development [16]. Autop-
olysialylation of PST is not required for, but does enhance,
polysialylation of NCAM [67]. Both STX and PST are integral mem-
brane proteins of Golgi membranes, and their catalytic domains are
located in the lumen of Golgi vesicles.
2.10. Oligosialylated gangliosides in plasma membranes
Gangliosides are mono-, di- or oligosialylated glycosphingolipids
localized mainly in the outer leaﬂet of the plasma membrane and
highly enriched in the vertebrate nervous system. In mammals,
mono-, di-, tri-, tetra-, and penta-sialogangliosides were identiﬁed
[68]. Penta-sialoganglioside GP1c contains two Sia chains: one
(DP=3) is attached to the internal galactose, and the other
(DP=2) is attached to the terminal galactose (Fig. 3D). In ﬁsh
brain, hexa-sialogangliosides were isolated [69], with the additional
sixth Sia residue attached to GalNAc. Tetra-sialoganglioside GQ1b
contains two oligoSia chains (each of DP=2) which are attached to
the internal and terminal galactose. GQ1b is the major ganglioside
in lipid membranes extracted from rat cerebellar granules as DRM
(detergent-resistant membranes) [70]. C-series gangliosides (GT3,
GT2, GT1c, GQ1c, GP1c) are characterized by the presence of oligoSia
chain with DP=3 attached to the inner galactose [68]; they are pre-
sent in high concentration in adult ﬁsh brain of certain species, in
squid tissues and in mammalian eye lenses [71]. They are temporarily
expressed at embryonic stages of mammalian brain [72], they are
transiently expressed in the human cerebrum during prenatal devel-
opment [73] and they may be involved in growth, differentiation and
migration of neuronal cells [74]. They are one of the components of
human milk that can play important role in neuronal development
[75]. C-series gangliosides have also been detected in tissues and
cells of the extraneural system [74]. A novel heptasialosyl c-series
ganglioside (GS1c) from embryonic chicken brain has been shown
to contain two Sia chains: one (DP=3) attached to the internal galac-
tose, and the other (DP=4) attached to the terminal galactose [71].
Oligosialogangliosides are also present in lipid rafts in neural mem-
branes [76] and in lipid rafts of plasma membrane of sea urchin
sperm ﬂagella [60,61]. The ﬁrst evidence for a natural oligoSia chain
of DP=4 in glycosphingolipid in sea urchin sperm has been reported
[60].
Oligosialogangliosides are implicated in various cellular functions,
including growth, differentiation, cellular recognition and adhesion,
immune response, and signal transduction [68,77]. Oligosialylated
gangliosides protect human spermatozoa from reactive oxygen spe-
cies (ROS)-induced DNA and membrane damage [78]. Oligosialogan-
gliosides are also found in various subcellular organelles, including
nuclear membranes. In nuclear membranes of brain cells, they are
developmentally-regulated and may function in proliferation and
differentiation of these cells [77]. Gangliosides can increase the ex-
citability of voltage-dependent sodium channels [79].
2.11. Oligosialylated membrane proteins
OligoSia chains are observed not only on mammalian brain gangli-
osides but also on glycoproteins including NCAM [19,80–81]. Di- and
oligoSia chains have been found on a large number of pig brain glyco-
proteins [80] and this ﬁnding reveals a surprising diversity in the
number and molecular weight of proteins distinct from NCAM that
are covalently modiﬁed by these glycotopes. HPLC analysis has dem-
onstrated the presence of oligoSia on membrane-associated glyco-
peptides from adult chicken brain [81]. TriSia chains have been
detected by a triSia-speciﬁc monoclonal antibody both on ganglio-
sides and on glycoproteins in the homogenates derived from
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to be involved in oligodendrocyte differentiation [19] similar to the
case with the triSia structure on gangliosides. Sulfated oligoSia units
have been identiﬁed in the O-linked glycan of the sea urchin egg re-
ceptor for sperm (a cell surface glycoprotein) [82]. α2-8-linked oligo-
Sia chains with DP=5–7 occur on α5 subunit of integrin (an integral
protein of the plasma membrane) in several human cells and these
oligoSia play important roles in cell adhesion to ﬁbronection [83]. Oli-
goSia chains on gangliosides and glycoproteins can serve as initiating
sites for polySia chain polymerization by STX/PST polysialyltrans-
ferases and the bacterial polysialyltransferase [1,84]. However, in
vivo evidence for the formation of long polySia chains on gangliosides
by a polysialyltransferase is lacking. Polysialyltransferase ST8SiaIII
may be responsible for synthesis of some oligoSia chains on proteins
[19,64] because ST8SiaIII gene expression correlates with expression
of the triSia epitope on glycoproteins in developing mouse brain [19].
In summary, both long polySia chains attached to membrane pro-
teins and short oligoSia chains attached to glycosphingolipids or to
membrane proteins are found mostly in neural plasma membrane,
in human milk, and sometimes in membrane rafts, and appear to
have similar functions in neuronal development, in cellular recogni-
tion, adhesion, immune response, signal transduction and ion channel
electrophysiology. PolySia are found in prokaryotic cells (e.g. E. coli
K1) and in animal cells — invertebrates (e.g. sea urchin) and verte-
brates (e.g. humans); there are no reports on polySia in protist,
fungi or plant cells.
3. Modes of poly/oligoSia attachment to membranes
Fig. 3 shows attachment modes of poly/oligoSia chains to the
membrane characterized to date [2,5,28,39,85–88]. The reducing
end of the chain can be conjugated to:
- an integral membrane protein — through core oligosaccharides
N-linked to an asparagine located in the polypeptide chain
(Fig. 3A), e.g. NCAM-180;
- an integral membrane protein — through core oligosaccharides O-
linked to a serine or a threonine located in the polypeptide chain
(Fig. 3B), e.g. Neuropilin 2 [62], glycoprotein of sea urchin sperm
[58,59], CD36 glycoprotein [54], and NCAM [38];
- a protein attached to the membrane through a glycosylphosphati-
dylinositol (GPI) lipid anchor (Fig. 3C). Studies suggest [37,87,89]
that polySia conjugation may occur through core oligosaccharides
O-linked to a serine or a threonine located in the polypeptide
chain, e.g. NCAM-120, however there is not a direct evidence for
the O-linked version of the GPI-anchored proteins;
- a glycosphingolipid — through core oligosaccharide chains in a
ceramide lipid (Fig. 3D) in the case of an oligosialylated ganglio-
side GP1c [68];
- a phospholipid — through the phosphate group (Fig. 3E) in the
case of polySia in bacterial K1 capsule [28].
The attachment to the core oligosaccharide of a glycoprotein is
usually through an α-2,3-linkage to a galactose; however, the O-
linked polySia chain on Flagellasialin from sea urchin sperm is linked
to a GalNAc residue through an α-2,6-linkage [58]. The attachment of
oligoSia to a glycosphingolipid is usually through an α-2,3-linkage to
the internal and/or terminal galactose; however, the oligosialoglyco-
lipids from the surface of sea urchin sperm have been reported to
be (8Neu5Acα2)n→6Glc [60]. The attachment to the phosphate moi-
ety of a phospholipid is proposed to be through the glycosidic linkage
via the C-2 hydroxyl group [28].
4. Biophysicalmechanisms of the activity ofmembrane poly/oligoSia
The mechanisms of poly/oligoSia activity are based on a combina-
tion of interactions between two molecules (through repulsive and/or attractive interactions) and interactions between a membrane
and a molecule (through modulation of surface charge density, pH
at the membrane surface, and membrane potentials) (Fig. 4).
4.1. Repulsive interactions mediated by membrane polySia: shielding/
masking effects
Long, negatively-charged linear polySia chain has a particularly
high degree of hydration and thus occupies a volume approximately
three times larger than its carrier protein [90]. Therefore, polySia
can shield the carrier protein as well as the host membrane from
binding to other molecules or apposing membrane of another cell
(Fig. 4). This effect was observed in the case of:
- model systems— through quantitative biophysical analysis of lipid
bilayers containing polySia-NCAM [91];
- homophilic (between two molecules of the same kind) cis (in the
plane of the hostmembrane) dimerization of NCAMs [92] (Fig. 4A1);
- homophilic trans (between two apposing membranes) interac-
tions of NCAMs [92] (Fig. 4A2);
- heterophilic (between two molecules of different kind) cis inter-
actions — between NCAM and NMDA receptors [93,94] (Fig. 4B1);
- heterophilic trans interactions [7,95] (Fig. 4B2).
Expression of polySia on NCAM may function as a switch, regulat-
ing whether NCAM is involved in cell adhesion (non-polysialylated
NCAM) or signaling (polysialylated NCAM) [96].
In the case of bacterial cells invading human brain, polySia chains
render bacterial cells resistant to phagocytosis by forming a capsule
surrounding the outer bacterial membrane that masks immunogenic
surface components of the outer membrane [19]. OligoSia in ganglio-
sides can function in masking galactose, thereby preventing interac-
tion with galactose-binding receptors [97].
It should be noted that the shielding/masking effect may not always
be related to the repulsive interaction because attractive (electrostatic)
interaction of polySia with some basic amino acid residues may also
shield some structural units of membrane components.
4.2. Attractive interactions mediated by membrane poly/oligoSia
There are several different binding partners of long polySia chains
reported to date (Fig. 4C1— a membrane protein partner, Fig. 4C2— a
membrane lipid partner, Fig. 4C3 — a non-membrane partner):
- Extracellular histone H1 (a non-membrane partner) [98]. This
binding may have a role in functional development and regenera-
tion of the nervous system.
- Endo-N neuraminidase from bacteriophages of the K1 family (a
non-membrane partner) [99,100]. Endo-N neuraminidase enables
bacteriophages to gain access to the bacterial outer membrane
and to inject their genetic material.
- Brain-derived neurotropic factor (BDNF, a protein dimer, a non-
membrane partner) [101]. The minimum DP of polySia required
for binding is 12. The complex formation of BDNF with polySia
up-regulates growth or/and survival of neuroblastoma cells.
- Heparan sulfate proteoglycans (non-membrane partners) [102]. In-
teraction of polysialylated NCAM with heparan sulfate proteogly-
cans may modulate synaptogenesis and activity-dependent
remodeling of synapses [103].
- Cytokine CCL21 (a peptide, a non-membrane partner) [104]. The
interaction of polySia on Neuropilin-2 in dendritic cells with
CCL21 regulates the migratory capacity of human dendritic cells.
- Anti-polySia antibodies (non-membrane partners) [105].
- Polybasic motif of polysialyltransferases (membrane protein part-
ners) [106].
- Other polysialic acid chains— resulting in the formation of ﬁlament
bundles in the presence of calcium ions [107]. These ﬁlament
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- Phospholipids (membrane lipid partners in the lipid bilayer mem-
brane). PolySia chains can associate with phosphatidylcholine bi-
layers, incorporate into the polar part of a phospholipid
monolayer, modulate cis interactions between phosphatidylcho-
line molecules, and facilitate trans interactions between apposing
phospholipid vesicles [108]. Similar phenomena are observed for
RNA aptamers [109–111]: RNA aptamers, selected for binding to
liposomes, can associate with phospholipid liposomes, incorpo-
rate into the polar part of the lipid bilayer and modulate lipid
interactions.
- Positively-charged long-chain bases (membrane lipid partners in
the lipid bilayer membrane) [112]. These studies suggest that a
polySia chain can act as a multi-bridge that mediates cis interac-
tions between different components of a lipid membrane, disruptsmembrane aggregates, and mediates trans interactions between
lipids (including long-chain bases) in apposing membranes.
The binding to oligoSia chains (in oligosialylated gangliosides) is
observed in the case of:
- Viruses: inﬂuenza virus [113], human polyomavirus, BKV [114],
minute virus of mice, MUM [115]. The binding of viruses to oligo-
sialylated gangliosides on plasma membrane of host cell facilitates
virus entry into the cell.
- E. coli K1 polysialyltransferase (a membrane protein partner) [84].
- Sialic-acid-binding immunoglobulin-like lectins, Siglecs (membrane
protein partners) [116,117]. These interactions may inﬂuence the
function of Siglec-7 as an inhibitory receptor on natural killer
(NK) cells [118,119]. Siglec-7 and Siglec-11 exhibit a preference
for α-2,8-linked disialic acids [116].
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bacterial strains, e.g. tetanus neurotoxin and botulinum neuro-
toxins [120]. Binding of these toxins to oligosialylated gangliosides
in the outer leaﬂet of the neuronal plasma membrane is followed
by their uptake through endocytosis via retrieval of synaptic
vesicles.
- Anti-ganglioside antibodies (non-membrane partners) [121].
Binding of these antibodies to oligosialylated gangliosides plays a
role in the pathophysiology of Guillain–Barré syndrome and Fisher
syndrome.4.3. Modulation of surface charge density, pH at the membrane surface,
and membrane potentials by membrane poly/oligoSia
Poly/oligoSia chains can be found at the outer surface of plasma/
bacterial membrane after transmembrane translocation of poly/oligoSia
chains or after incorporation of poly/oligoSia chains through fusion of
transport vesicles or adsorption of poly/oligoSia chains. Poly/oligoSia
chains at the outer membrane surfaces increase surface density of nega-
tive charges, decrease pH at the membrane surface, decrease the electric
ﬁeld inside the membrane, and decrease the absolute value of negative
transmembrane potential (deﬁned as the difference between the poten-
tials of the inner and outer surfaces of the membrane) [108,122–128]
(Fig. 4). These modiﬁcations can further lead to changes in transmem-
brane channel/membrane carrier activities [129,130], in protein localiza-
tion and function with impact on malignant transformation [131–133],
and in mitochondrial release of pro-apoptotic factors [134]. Therefore,
the reported effect of polysialylated NCAM on membrane channel pro-
tein activity [93,94,135] may not result from direct interaction of polySia
chains with the channel protein but from indirect membrane effects on
the channel, resulting from modulation of local surface charge density,
pH at the membrane surface, or/and membrane potentials by polySia.
Although other polyanionicmolecules (e.g. nucleic acids) can have sim-
ilar effects on membranes, polySia and also some glycosaminoglycans
(in syndecans and glypicans) are unique because they are the only poly-
anions permanently attached to membranes of eukaryotic cells
reported to date.
5. Future perspective
5.1. Current controversies and research questions
Membrane translocation and membrane insertion:
- What are the molecular mechanisms of transmembrane transloca-
tion of polySia chains in bacterial cells? There is still a controversy
on the nature of the molecule to which a polySia chain is attached
during this translocation in the inner bacterial membrane. Is it a
phospholipid or undecaprenyl phosphate or an endogenous ac-
ceptor protein? Although the transmembrane proton gradient
and the membrane electric potential gradient were identiﬁed as
the driving forces for transmembrane translocation of polySia
[123–127], it is still unknown whether these gradients act directly
on polySia, or on undecaprenyl phosphate [136–139], on an accep-
tor protein [31] or on a membrane transport protein [22–24] facil-
itating this translocation.
- What are the molecular mechanisms of the insertion of polysialy-
lated NCAM/SynCAM into the synaptic plasmamembrane? The in-
creased concentration of polySia at the synapse could function as a
spacer modifying adhesion forces thus modulating the dynamic
balance between stability and plasticity of synaptic connections
[5]. The trafﬁcking of polySia on NCAM/SynCAM to the synapse
most likely involve vesicles derived from trans Golgi network
but a synapse transmembrane system for polySia membrane in-
sertion/translocation has not yet been identiﬁed.- Is polySia involved in the disruption of membrane rafts? PolySia
can disrupt lipid aggregates in model system [112] and the palmi-
toylation of NCAM results in NCAM translocation to lipid rafts
[140], therefore polySia on NCAM may interact with rafts. Since
rafts are involved in cellular signaling, an indirect mechanism of
regulation of cellular signaling may involve the disruption of
rafts by polySia.
Biosynthesis of membrane polySia:
- How many sialyltransferases are required to create a membrane
polySia chain? There is a single-enzyme hypothesis and an alter-
native theory that more than one sialyltransferase is required to
catalyze both chain initiation and polymerization [1]. The ﬁrst
“initiase” transfers Sia to Sia-Gal-acceptors, and the second “poly-
merase” transfers additional Sia to the disialyl-Gal-acceptors.
- Are microRNAs involved in the regulation of the expression of
membrane polySia? Both polySia [1] andmicroRNAs [141] are cor-
related with regulating metastasis in a number of human tumors;
however any connections between these two players have not
been determined.
- PolySia in neurodegenerative disorders: Is polySia involved in
neurodegenerative disorders (such as Alzheimer's disease
[142], Huntington's disease [143]) or Spinal Muscular Atrophy
(SMA)? SMA is a genetic neurodegenerative disorder resulting
in the disruptions in synaptic function and aberrant guidance
of motor axons [144]; since the elimination of polySia can in-
duce similar effects, polysialylated proteins may be involved in
this disorder.
5.2. Emerging new applications of polySia research in medicine
- Abnormally low level of polySia is a major risk factor in patho-
physiology of schizophrenic brains [94,145–147] and may be in-
volved in other neuro-psychiatric disorders [148].
- PolySia expressed on cancer cells contributes to in metastases of
some cancers [22]. Expression of polySia on the surface of cancer
cells may facilitate cell detachment, tumor growth, invasion, and
metastasis. We propose that these effects may result from poly-
Sia-induced decrease of pH at the surface of cancer cells.
- Chemotherapeutic inhibition of polysialyltransferases (but not
monosialyltransferases) is an emerging area of research with di-
rect impact on cancer metastasis [1].
- Engineered over-expression of polySia or polySia-mimetic peptide
treatment has a potential for producing favorable conditions for
repair of neural tissue in adult mammalian central nervous system
[149,150]. Therapeutic beneﬁts were reported for engineered ex-
pression of polySia on scar astrocytes, transplantation of Schwann
cells engineered to expressed polySia, and delivery of neural pro-
genitors to a brain injury (reviewed in Ref. [149]). There are sever-
al other examples (some of them discussed in previous chapters)
showing the importance of membrane polySia in human health
and disease, and in tissue repair therapeutics.
- Posttranslational modiﬁcation of therapeutic proteins with poly-
Sia chains is one means of improving their circulating half-life
[151]
- PolySia can be modiﬁed with a long-chain hydrocarbon and the
resultant conjugates can self-assembled into micelles for encapsu-
lation of hydrophobic drug molecules [152]
- Discovery of new vaccines against bacterial meningitis disease
caused by E. coli K1 and N. meningitidis serogroups B and C, is im-
portant because of the emergence of pathogens with increasing
resistance to antimicrobial drugs; also a licensed vaccine provid-
ing broad protection against this disease is not yet available
[153,154].
- Glycan proﬁling using mass spectrometry seems to be an emerg-
ing tool for polySia research [55,151].
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Although the typical, widely recognized function of polySia chains
is to mediate repulsion between apposing membranes, the emerging
picture is much more complex and includes the trans/cis repulsion
between polySia and other membrane molecules, trans/cis attraction
between poly/oligoSia and membrane components, attraction be-
tween poly/oligoSia and non-membrane molecules, modulation of
the membrane potentials, surface pH, and surface charge density.
Thus analyses of future experimental data related to polySia-mediated
membrane phenomena will have to take into account the complexity
of the poly/oligoSia-membrane system.Acknowledgements
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